Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Altimmune, Appili, Arctic Vision, Astrazeneca, Casi, Cytodyn, Dr. Reddy’s, Innocare, Innovation, Innovent Biologics, Inotrem, Juventas Cell Therapy, Merck, Shenyang Tonglian, Takeda.